Development of a candidate vaccine to hepatitis C virus using an innovative virus like particles (VLPs) technology
Development of a candidate vaccine to hepatitis C virus using an innovative virus like particles (VLPs) technology
使用创新的病毒样颗粒 (VLP) 技术开发丙型肝炎病毒候选疫苗
批准号：
198509
负责人：
Leclerc Denis
金额：
$7.28万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-09-01 至 2010-09-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The world health organisation (WHO) estimates that hepatitis C virus (HCV) infection affects about 200 million people, which correspond to 3% of the world population. It is considered as one of the most devastating infectious disease worldwide.
Because H
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer.
-
批准号：473345
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2022
-
负责人：Leclerc Denis
-
依托单位：
COVID-19 Variant Supplement - Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2
-
批准号：443203
-
项目类别：Operating Grants
-
资助金额：$3.64万
-
财政年份：2021
-
负责人：Leclerc Denis
-
依托单位：
Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2
-
批准号：422762
-
项目类别：Operating Grants
-
资助金额：$52.28万
-
财政年份：2020
-
负责人：Leclerc Denis
-
依托单位：
Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate.
-
批准号：365665
-
项目类别：Operating Grants
-
资助金额：$18.21万
-
财政年份：2017
-
负责人：Leclerc Denis
-
依托单位：
Prevention and control of chronic and respiratory viral diseases using PapMV nanoparticles.
-
批准号：278016
-
项目类别：Operating Grants
-
资助金额：$55.39万
-
财政年份：2013
-
负责人：Leclerc Denis
-
依托单位：
Disserting the mechanisms of palmitoylation of the HCV core protein and its influence on formation of lipid droplets; a crucial function in the virus life cycle.
-
批准号：199122
-
项目类别：Operating Grants
-
资助金额：$42.35万
-
财政年份：2010
-
负责人：Leclerc Denis
-
依托单位：
海外基金
